| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | tRNA binding | 3.99e-05 | 87 | 44 | 4 | GO:0000049 | |
| GeneOntologyMolecularFunction | dynein light chain binding | 3.09e-04 | 12 | 44 | 2 | GO:0045503 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 3.58e-04 | 614 | 44 | 7 | GO:0140657 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 4.93e-04 | 70 | 44 | 3 | GO:0003777 | |
| GeneOntologyMolecularFunction | dynein heavy chain binding | 6.32e-04 | 17 | 44 | 2 | GO:0045504 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.23e-03 | 118 | 44 | 3 | GO:0003774 | |
| GeneOntologyMolecularFunction | tubulin binding | 2.41e-03 | 428 | 44 | 5 | GO:0015631 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | 2.48e-03 | 1099 | 44 | 8 | GO:0008092 | |
| GeneOntologyMolecularFunction | snoRNA binding | 2.55e-03 | 34 | 44 | 2 | GO:0030515 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 3.01e-03 | 37 | 44 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | DNA secondary structure binding | 3.68e-03 | 41 | 44 | 2 | GO:0000217 | |
| GeneOntologyBiologicalProcess | ribosome biogenesis | 3.84e-08 | 336 | 45 | 9 | GO:0042254 | |
| GeneOntologyBiologicalProcess | rRNA processing | 6.19e-07 | 230 | 45 | 7 | GO:0006364 | |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex biogenesis | 1.40e-06 | 515 | 45 | 9 | GO:0022613 | |
| GeneOntologyBiologicalProcess | rRNA metabolic process | 2.04e-06 | 275 | 45 | 7 | GO:0016072 | |
| GeneOntologyBiologicalProcess | ribosomal small subunit biogenesis | 3.71e-06 | 108 | 45 | 5 | GO:0042274 | |
| GeneOntologyBiologicalProcess | organelle transport along microtubule | 5.91e-05 | 97 | 45 | 4 | GO:0072384 | |
| GeneOntologyBiologicalProcess | RNA processing | DHX16 SART1 CIR1 FCF1 WDR3 KRI1 WBP11 TRMT10A UPF3B LYAR NOP56 PDCD7 | 6.31e-05 | 1500 | 45 | 12 | GO:0006396 |
| GeneOntologyBiologicalProcess | transport along microtubule | 6.77e-05 | 197 | 45 | 5 | GO:0010970 | |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent intracellular transport | 1.27e-04 | 225 | 45 | 5 | GO:0030705 | |
| GeneOntologyBiologicalProcess | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.07e-04 | 10 | 45 | 2 | GO:0000447 | |
| GeneOntologyBiologicalProcess | microtubule-based transport | 2.18e-04 | 253 | 45 | 5 | GO:0099111 | |
| GeneOntologyBiologicalProcess | maturation of SSU-rRNA | 2.35e-04 | 55 | 45 | 3 | GO:0030490 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | 6.68e-04 | 493 | 45 | 6 | GO:0007018 | |
| GeneOntologyBiologicalProcess | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 6.96e-04 | 18 | 45 | 2 | GO:0000479 | |
| GeneOntologyBiologicalProcess | RNA splicing | 7.34e-04 | 502 | 45 | 6 | GO:0008380 | |
| GeneOntologyCellularComponent | preribosome | 1.05e-04 | 114 | 45 | 4 | GO:0030684 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 5.68e-04 | 1377 | 45 | 10 | GO:0140513 | |
| GeneOntologyCellularComponent | small-subunit processome | 5.87e-04 | 76 | 45 | 3 | GO:0032040 | |
| GeneOntologyCellularComponent | microtubule | 9.35e-04 | 533 | 45 | 6 | GO:0005874 | |
| GeneOntologyCellularComponent | cytoplasmic dynein complex | 1.21e-03 | 24 | 45 | 2 | GO:0005868 | |
| GeneOntologyCellularComponent | 90S preribosome | 1.77e-03 | 29 | 45 | 2 | GO:0030686 | |
| GeneOntologyCellularComponent | MLL1 complex | 2.16e-03 | 32 | 45 | 2 | GO:0071339 | |
| GeneOntologyCellularComponent | nuclear speck | 2.26e-03 | 431 | 45 | 5 | GO:0016607 | |
| GeneOntologyCellularComponent | MLL1/2 complex | 2.29e-03 | 33 | 45 | 2 | GO:0044665 | |
| HumanPheno | Short attention span | CARS1 SMARCA2 ANKRD11 DNAJC21 KMT2A ANKRD17 WBP11 UPF3B NOP56 SMC5 DYNC1I2 ZNF292 | 2.74e-08 | 517 | 19 | 12 | HP:0000736 |
| HumanPheno | Reduced attention regulation | CARS1 SMARCA2 ANKRD11 DNAJC21 KMT2A ANKRD17 WBP11 UPF3B NOP56 SMC5 DYNC1I2 ZNF292 | 3.33e-08 | 526 | 19 | 12 | HP:5200044 |
| HumanPheno | Hyperactivity | CARS1 SMARCA2 ANKRD11 DNAJC21 KMT2A ANKRD17 WBP11 UPF3B NOP56 SMC5 DYNC1I2 ZNF292 | 6.52e-08 | 558 | 19 | 12 | HP:0000752 |
| HumanPheno | Disinhibition | CARS1 SMARCA2 ANKRD11 DNAJC21 KMT2A ANKRD17 WBP11 UPF3B NOP56 SMC5 WASF1 DYNC1I2 ZNF292 | 3.87e-07 | 807 | 19 | 13 | HP:0000734 |
| HumanPheno | Inappropriate behavior | CARS1 SMARCA2 ANKRD11 DNAJC21 KMT2A ANKRD17 WBP11 UPF3B NOP56 SMC5 WASF1 DYNC1I2 ZNF292 | 3.87e-07 | 807 | 19 | 13 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | CARS1 SMARCA2 ANKRD11 DNAJC21 KMT2A ANKRD17 WBP11 UPF3B NOP56 SMC5 WASF1 DYNC1I2 ZNF292 | 3.87e-07 | 807 | 19 | 13 | HP:5200123 |
| HumanPheno | Social disinhibition | CARS1 SMARCA2 ANKRD11 DNAJC21 KMT2A ANKRD17 WBP11 UPF3B NOP56 SMC5 WASF1 DYNC1I2 ZNF292 | 3.87e-07 | 807 | 19 | 13 | HP:5200029 |
| HumanPheno | Attention deficit hyperactivity disorder | CARS1 SMARCA2 ANKRD11 ANKRD17 WBP11 UPF3B NOP56 SMC5 DYNC1I2 ZNF292 | 5.23e-07 | 413 | 19 | 10 | HP:0007018 |
| HumanPheno | Abnormally increased volition | CARS1 SMARCA2 ANKRD11 DNAJC21 KMT2A ANKRD17 WBP11 UPF3B NOP56 SMC5 WASF1 DYNC1I2 ZNF292 | 9.42e-07 | 869 | 19 | 13 | HP:5200263 |
| HumanPheno | Abnormal social development | CARS1 SMARCA2 ANKRD11 DNAJC21 KMT2A ANKRD17 WBP11 UPF3B NOP56 SMC5 WASF1 DYNC1I2 ZNF292 | 1.59e-06 | 908 | 19 | 13 | HP:0025732 |
| HumanPheno | Reduced impulse control | CARS1 SMARCA2 ANKRD11 DNAJC21 KMT2A ANKRD17 WBP11 UPF3B NOP56 SMC5 WASF1 DYNC1I2 ZNF292 | 7.21e-06 | 1032 | 19 | 13 | HP:5200045 |
| HumanPheno | Impairment in personality functioning | CARS1 SMARCA2 ANKRD11 DNAJC21 KMT2A ANKRD17 WBP11 UPF3B NOP56 SMC5 WASF1 DYNC1I2 ZNF292 | 2.31e-05 | 1141 | 19 | 13 | HP:0031466 |
| HumanPheno | Abnormality of globe location or size | CARS1 SMARCA2 ANKRD11 DNAJC21 KMT2A ANKRD17 TRMT10A SMC5 WASF1 AP3D1 DYNC1I2 KIF21A ZNF292 | 6.31e-05 | 1246 | 19 | 13 | HP:0000489 |
| HumanPheno | Abnormal motivation | CARS1 SMARCA2 ANKRD11 DNAJC21 KMT2A ANKRD17 WBP11 UPF3B NOP56 SMC5 WASF1 DYNC1I2 ZNF292 | 7.36e-05 | 1263 | 19 | 13 | HP:5200275 |
| HumanPheno | Abnormal volitional state | CARS1 SMARCA2 ANKRD11 DNAJC21 KMT2A ANKRD17 WBP11 UPF3B NOP56 SMC5 WASF1 DYNC1I2 ZNF292 | 7.36e-05 | 1263 | 19 | 13 | HP:0025780 |
| HumanPheno | Recurrent maladaptive behavior | CARS1 SMARCA2 ANKRD11 DNAJC21 KMT2A ANKRD17 WBP11 UPF3B NOP56 SMC5 WASF1 DYNC1I2 ZNF292 | 9.58e-05 | 1293 | 19 | 13 | HP:5200241 |
| HumanPheno | Abnormal pinna morphology | CARS1 DHX16 SMARCA2 ANKRD11 DNAJC21 KMT2A WBP11 TRMT10A UPF3B SMC5 AP3D1 KIF21A ZNF292 | 1.01e-04 | 1299 | 19 | 13 | HP:0000377 |
| HumanPheno | Abnormality of globe location | CARS1 SMARCA2 ANKRD11 DNAJC21 KMT2A ANKRD17 TRMT10A WASF1 AP3D1 DYNC1I2 KIF21A ZNF292 | 1.31e-04 | 1122 | 19 | 12 | HP:0100886 |
| HumanPheno | Abnormality of the outer ear | CARS1 DHX16 SMARCA2 ANKRD11 DNAJC21 KMT2A WBP11 TRMT10A UPF3B SMC5 AP3D1 KIF21A ZNF292 | 1.39e-04 | 1337 | 19 | 13 | HP:0000356 |
| HumanPheno | Abnormal joint physiology | CARS1 DHX16 SMARCA2 ANKRD11 DNAJC21 KMT2A ANKRD17 WBP11 TRMT10A UPF3B WASF1 KIF21A MTRFR | 1.66e-04 | 1358 | 19 | 13 | HP:0034430 |
| HumanPheno | Abnormality of joint mobility | CARS1 DHX16 SMARCA2 ANKRD11 DNAJC21 KMT2A ANKRD17 WBP11 TRMT10A UPF3B WASF1 KIF21A MTRFR | 1.66e-04 | 1358 | 19 | 13 | HP:0011729 |
| HumanPheno | Abnormal eyelid morphology | CARS1 DHX16 SMARCA2 ANKRD11 DNAJC21 KMT2A ANKRD17 TRMT10A SMC5 WASF1 DYNC1I2 KIF21A ZNF292 | 2.47e-04 | 1408 | 19 | 13 | HP:0000492 |
| HumanPheno | Smooth philtrum | 4.59e-04 | 185 | 19 | 5 | HP:0000319 | |
| HumanPheno | Gray matter heterotopias | 4.61e-04 | 42 | 19 | 3 | HP:0002281 | |
| HumanPheno | Periventricular heterotopia | 4.61e-04 | 42 | 19 | 3 | HP:0007165 | |
| HumanPheno | Abnormality of the palpebral fissures | SMARCA2 ANKRD11 DNAJC21 KMT2A ANKRD17 TRMT10A SMC5 WASF1 DYNC1I2 ZNF292 | 4.62e-04 | 880 | 19 | 10 | HP:0008050 |
| HumanPheno | Abnormality of the hairline | 5.02e-04 | 294 | 19 | 6 | HP:0009553 | |
| HumanPheno | Synophrys | 5.86e-04 | 195 | 19 | 5 | HP:0000664 | |
| HumanPheno | Abnormality of the scalp hair | 6.24e-04 | 433 | 19 | 7 | HP:0100037 | |
| HumanPheno | Slanting of the palpebral fissure | SMARCA2 ANKRD11 DNAJC21 KMT2A ANKRD17 TRMT10A WASF1 DYNC1I2 ZNF292 | 6.38e-04 | 739 | 19 | 9 | HP:0200006 |
| HumanPheno | Bulbous nose | 6.73e-04 | 201 | 19 | 5 | HP:0000414 | |
| HumanPheno | Abnormal mandible morphology | CARS1 ANKRD11 DNAJC21 KMT2A WBP11 TRMT10A UPF3B SMC5 AP3D1 KIF21A ZNF292 | 7.05e-04 | 1118 | 19 | 11 | HP:0000277 |
| HumanPheno | Facial hypertrichosis | 7.53e-04 | 206 | 19 | 5 | HP:0002219 | |
| HumanPheno | Low posterior hairline | 7.85e-04 | 117 | 19 | 4 | HP:0002162 | |
| HumanPheno | Abnormality of the posterior hairline | 7.85e-04 | 117 | 19 | 4 | HP:0030141 | |
| HumanPheno | Microcephaly | CARS1 SMARCA2 ANKRD11 DNAJC21 KMT2A ANKRD17 WBP11 TRMT10A SMC5 AP3D1 DYNC1I2 ZNF292 | 7.88e-04 | 1341 | 19 | 12 | HP:0000252 |
| HumanPheno | Abnormal scalp morphology | 7.88e-04 | 450 | 19 | 7 | HP:0001965 | |
| HumanPheno | Aplasia/hypoplasia involving the skeleton | CARS1 SMARCA2 ANKRD11 DNAJC21 KMT2A TRMT10A UPF3B SMC5 WASF1 KIF21A MTRFR ZNF292 | 7.99e-04 | 1343 | 19 | 12 | HP:0009115 |
| HumanPheno | Broad-based gait | 8.10e-04 | 118 | 19 | 4 | HP:0002136 | |
| HumanPheno | Abnormal location of ears | DHX16 SMARCA2 ANKRD11 KMT2A WBP11 UPF3B SMC5 AP3D1 KIF21A ZNF292 | 8.36e-04 | 945 | 19 | 10 | HP:0000357 |
| HumanPheno | Decreased head circumference | CARS1 SMARCA2 ANKRD11 DNAJC21 KMT2A ANKRD17 WBP11 TRMT10A SMC5 AP3D1 DYNC1I2 ZNF292 | 8.66e-04 | 1354 | 19 | 12 | HP:0040195 |
| HumanPheno | Congenital abnormal hair pattern | 8.87e-04 | 327 | 19 | 6 | HP:0011361 | |
| HumanPheno | Epicanthus | 9.53e-04 | 614 | 19 | 8 | HP:0000286 | |
| HumanPheno | Hypoplasia of teeth | 1.04e-03 | 126 | 19 | 4 | HP:0000685 | |
| HumanPheno | Thin upper lip vermilion | 1.07e-03 | 339 | 19 | 6 | HP:0000219 | |
| HumanPheno | Thin lips | 1.07e-03 | 339 | 19 | 6 | HP:0000213 | |
| HumanPheno | Abnormality of the jaws | CARS1 ANKRD11 DNAJC21 KMT2A WBP11 TRMT10A UPF3B SMC5 AP3D1 KIF21A ZNF292 | 1.10e-03 | 1175 | 19 | 11 | HP:0000209 |
| HumanPheno | Abnormal jaw morphology | CARS1 ANKRD11 DNAJC21 KMT2A WBP11 TRMT10A UPF3B SMC5 AP3D1 KIF21A ZNF292 | 1.11e-03 | 1176 | 19 | 11 | HP:0030791 |
| HumanPheno | Wide nose | 1.13e-03 | 129 | 19 | 4 | HP:0000445 | |
| HumanPheno | Medial flaring of the eyebrow | 1.19e-03 | 228 | 19 | 5 | HP:0010747 | |
| HumanPheno | Delayed skeletal maturation | 1.31e-03 | 352 | 19 | 6 | HP:0002750 | |
| HumanPheno | Abnormality of the forehead | CARS1 SMARCA2 ANKRD11 KMT2A ANKRD17 WBP11 TRMT10A UPF3B SMC5 DYNC1I2 ZNF292 | 1.41e-03 | 1208 | 19 | 11 | HP:0000290 |
| HumanPheno | Motor delay | CARS1 SMARCA2 DNAJC21 KMT2A ANKRD17 TRMT10A SMC5 WASF1 DYNC1I2 KIF21A | 1.54e-03 | 1018 | 19 | 10 | HP:0001270 |
| HumanPheno | Micrognathia | CARS1 ANKRD11 DNAJC21 KMT2A TRMT10A UPF3B SMC5 KIF21A ZNF292 | 1.70e-03 | 843 | 19 | 9 | HP:0000347 |
| HumanPheno | Aplasia/Hypoplasia of the mandible | CARS1 ANKRD11 DNAJC21 KMT2A TRMT10A UPF3B SMC5 KIF21A ZNF292 | 1.73e-03 | 845 | 19 | 9 | HP:0009118 |
| MousePheno | embryonic lethality prior to organogenesis | DHX16 NUSAP1 EIF5B KRI1 KMT2A AFDN WBP11 INO80 PDCD7 MGA ZC3H4 GADD45GIP1 | 2.80e-05 | 1204 | 36 | 12 | MP:0013292 |
| MousePheno | embryonic lethality prior to tooth bud stage | DHX16 NUSAP1 EIF5B KRI1 KMT2A AFDN WBP11 INO80 PDCD7 MGA ZC3H4 GADD45GIP1 | 1.10e-04 | 1383 | 36 | 12 | MP:0013293 |
| MousePheno | embryonic lethality prior to organogenesis, complete penetrance | 1.11e-04 | 772 | 36 | 9 | MP:0014259 | |
| MousePheno | embryonic lethality prior to tooth bud stage, complete penetrance | 1.19e-04 | 779 | 36 | 9 | MP:0014257 | |
| MousePheno | abnormal inner cell mass morphology | 1.95e-04 | 113 | 36 | 4 | MP:0002718 | |
| Domain | DYNC1I1/DYNC1I2 | 5.42e-06 | 2 | 44 | 2 | IPR025956 | |
| Domain | Dynein_IC2 | 5.42e-06 | 2 | 44 | 2 | PF11540 | |
| Domain | BROMODOMAIN_2 | 1.22e-04 | 41 | 44 | 3 | PS50014 | |
| Domain | BROMO | 1.31e-04 | 42 | 44 | 3 | SM00297 | |
| Domain | Bromodomain | 1.31e-04 | 42 | 44 | 3 | IPR001487 | |
| Domain | - | 1.31e-04 | 42 | 44 | 3 | 1.20.920.10 | |
| Domain | WD40 | 3.44e-04 | 259 | 44 | 5 | PF00400 | |
| Domain | WD40 | 4.03e-04 | 268 | 44 | 5 | SM00320 | |
| Domain | WD40_repeat | 4.31e-04 | 272 | 44 | 5 | IPR001680 | |
| Domain | WD_REPEATS_1 | 4.76e-04 | 278 | 44 | 5 | PS00678 | |
| Domain | WD_REPEATS_2 | 4.84e-04 | 279 | 44 | 5 | PS50082 | |
| Domain | WD_REPEATS_REGION | 4.84e-04 | 279 | 44 | 5 | PS50294 | |
| Domain | WD40_repeat_dom | 6.43e-04 | 297 | 44 | 5 | IPR017986 | |
| Domain | - | 1.07e-03 | 333 | 44 | 5 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 1.10e-03 | 335 | 44 | 5 | IPR015943 | |
| Domain | Bromodomain_CS | 1.70e-03 | 26 | 44 | 2 | IPR018359 | |
| Domain | Helicase_C | 2.04e-03 | 107 | 44 | 3 | PF00271 | |
| Domain | HELICc | 2.04e-03 | 107 | 44 | 3 | SM00490 | |
| Domain | Helicase_C | 2.10e-03 | 108 | 44 | 3 | IPR001650 | |
| Domain | HELICASE_CTER | 2.15e-03 | 109 | 44 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.15e-03 | 109 | 44 | 3 | PS51192 | |
| Domain | DEXDc | 2.15e-03 | 109 | 44 | 3 | SM00487 | |
| Domain | Helicase_ATP-bd | 2.21e-03 | 110 | 44 | 3 | IPR014001 | |
| Domain | SNF2_N | 2.57e-03 | 32 | 44 | 2 | PF00176 | |
| Domain | SNF2_N | 2.57e-03 | 32 | 44 | 2 | IPR000330 | |
| Domain | BROMODOMAIN_1 | 3.43e-03 | 37 | 44 | 2 | PS00633 | |
| Domain | Bromodomain | 3.61e-03 | 38 | 44 | 2 | PF00439 | |
| Domain | - | 4.00e-03 | 40 | 44 | 2 | 4.10.1000.10 | |
| Domain | ZnF_C3H1 | 5.71e-03 | 48 | 44 | 2 | SM00356 | |
| Domain | zf-CCCH | 5.95e-03 | 49 | 44 | 2 | PF00642 | |
| Domain | WD40_repeat_CS | 6.76e-03 | 164 | 44 | 3 | IPR019775 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 3.00e-05 | 724 | 33 | 9 | M16843 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 6.38e-05 | 612 | 33 | 8 | MM15547 | |
| Pathway | REACTOME_MRNA_SPLICING | 9.62e-05 | 201 | 33 | 5 | MM15411 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.24e-04 | 212 | 33 | 5 | M14033 | |
| Pathway | REACTOME_RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL | 3.65e-04 | 60 | 33 | 3 | M27613 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 4.27e-04 | 277 | 33 | 5 | MM15414 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 4.71e-04 | 283 | 33 | 5 | M13087 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ANKRD11 SART1 EIF5B WDR3 KRI1 KMT2A NCOR2 AFDN WBP11 LYAR NOP56 SMC5 UBN2 MGA ZC3H4 SURF6 | 4.17e-14 | 954 | 46 | 16 | 36373674 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | SART1 EIF5B DNAJC21 ANKRD17 INO80 NOP56 SMC5 UBN2 MGA ZC3H4 DYNC1I2 ZNF292 GKAP1 | 6.71e-12 | 724 | 46 | 13 | 36232890 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DHX16 SMARCA2 SART1 EIF5B WDR3 ANKRD17 NCOR2 AFDN LYAR NOP56 MGA MICAL2 AP3D1 DYNC1I2 KIF21A | 1.08e-10 | 1353 | 46 | 15 | 29467282 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NUSAP1 SART1 WDR3 KRI1 DNAJC21 UPF3B LYAR NOP56 PDCD7 SMC5 AP3D1 SURF6 | 2.11e-10 | 759 | 46 | 12 | 35915203 |
| Pubmed | SMARCA2 ANKRD11 NUSAP1 EIF5B WDR3 DNAJC21 KMT2A ANKRD17 AFDN INO80 LYAR PDCD7 UBN2 SURF6 MTRFR | 4.37e-10 | 1497 | 46 | 15 | 31527615 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ANKRD11 SART1 DNAJC21 KMT2A NOP56 SMC5 ZC3H4 AP3D1 SURF6 ZNF292 | 8.35e-10 | 497 | 46 | 10 | 36774506 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DHX16 SART1 EIF5B WBP11 INO80 LYAR NOP56 PDCD7 ZC3H6 ZC3H4 AP3D1 SURF6 ZNF292 | 9.35e-10 | 1082 | 46 | 13 | 38697112 |
| Pubmed | DHX16 NUSAP1 FCF1 WDR3 KRI1 KMT2A ANKRD17 WBP11 UPF3B LYAR NOP56 PDCD7 AP3D1 GADD45GIP1 | 1.51e-09 | 1371 | 46 | 14 | 36244648 | |
| Pubmed | DHX16 SMARCA2 NUSAP1 SART1 EIF5B WDR3 KMT2A NCOR2 WBP11 INO80 LYAR SMC5 | 5.52e-09 | 1014 | 46 | 12 | 32416067 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | CARS1 SMARCA2 SART1 WDR3 ANKRD17 UPF3B NOP56 AP3D1 DYNC1I2 KIF21A BRWD1 | 1.03e-08 | 847 | 46 | 11 | 35235311 |
| Pubmed | DHX16 SMARCA2 SART1 EIF5B WDR3 KRI1 KMT2A ANKRD17 AFDN SURF6 | 1.13e-08 | 653 | 46 | 10 | 22586326 | |
| Pubmed | SART1 CIR1 EIF5B ANKRD17 NCOR2 LYAR NOP56 ZC3H4 GADD45GIP1 SURF6 | 1.16e-08 | 655 | 46 | 10 | 35819319 | |
| Pubmed | 1.25e-08 | 483 | 46 | 9 | 36912080 | ||
| Pubmed | SMARCA2 NUSAP1 KRI1 KMT2A ANKRD17 NCOR2 WBP11 INO80 NOP56 UBN2 MGA GADD45GIP1 SURF6 | 2.58e-08 | 1429 | 46 | 13 | 35140242 | |
| Pubmed | DHX16 NUSAP1 EIF5B WDR3 WBP11 LYAR NOP56 DYNC1I1 DYNC1I2 SURF6 | 2.94e-08 | 723 | 46 | 10 | 34133714 | |
| Pubmed | SART1 ANKRD17 NCOR2 AFDN WBP11 NOP56 UBN2 MGA WASF1 ZC3H4 KIF21A | 3.81e-08 | 963 | 46 | 11 | 28671696 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 4.37e-08 | 148 | 46 | 6 | 32538781 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | DHX16 SMARCA2 SART1 EIF5B KMT2A ANKRD17 NCOR2 AFDN ZC3H4 DYNC1I2 | 5.56e-08 | 774 | 46 | 10 | 15302935 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ANKRD11 NUSAP1 SART1 WDR3 KMT2A NCOR2 INO80 LYAR NOP56 UBN2 MGA SURF6 | 8.06e-08 | 1294 | 46 | 12 | 30804502 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 8.90e-08 | 608 | 46 | 9 | 36089195 | |
| Pubmed | HIV-1 capsids bind and exploit the kinesin-1 adaptor FEZ1 for inward movement to the nucleus. | 1.21e-07 | 8 | 46 | 3 | 25818806 | |
| Pubmed | 1.28e-07 | 847 | 46 | 10 | 35850772 | ||
| Pubmed | SMARCA2 SART1 ANKRD17 NCOR2 INO80 LYAR MGA ZC3H4 GADD45GIP1 SURF6 BRWD1 | 1.68e-07 | 1116 | 46 | 11 | 31753913 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | CARS1 SART1 EIF5B KRI1 WBP11 UPF3B LYAR NOP56 ZC3H4 AP3D1 DYNC1I2 KIF21A | 2.12e-07 | 1415 | 46 | 12 | 28515276 |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 2.23e-07 | 678 | 46 | 9 | 30209976 | |
| Pubmed | SART1 EIF5B DNAJC21 KMT2A WBP11 NOP56 CCDC191 AP3D1 DYNC1I1 DYNC1I2 KIF21A ZNF292 | 2.59e-07 | 1442 | 46 | 12 | 35575683 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 3.16e-07 | 341 | 46 | 7 | 32971831 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 3.65e-07 | 949 | 46 | 10 | 36574265 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 3.69e-07 | 349 | 46 | 7 | 25665578 | |
| Pubmed | The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival. | 4.54e-07 | 220 | 46 | 6 | 31822558 | |
| Pubmed | SMARCA2 SART1 EIF5B DNAJC21 ANKRD17 NCOR2 UPF3B MGA ZC3H6 MICAL2 KIF21A | 5.07e-07 | 1247 | 46 | 11 | 27684187 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 5.32e-07 | 989 | 46 | 10 | 36424410 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DHX16 NUSAP1 SART1 EIF5B WDR3 KRI1 DNAJC21 ANKRD17 LYAR NOP56 SURF6 | 5.49e-07 | 1257 | 46 | 11 | 36526897 |
| Pubmed | A catalogue of putative HIV-1 protease host cell substrates. | 6.48e-07 | 124 | 46 | 5 | 22944692 | |
| Pubmed | WDR3 AFDN WBP11 PDCD7 FEZ1 MICAL2 DYNC1I1 KIF21A SURF6 ZNF292 BRWD1 | 6.81e-07 | 1285 | 46 | 11 | 35914814 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DHX16 SART1 EIF5B WDR3 AFDN WBP11 NOP56 MGA ZC3H4 GADD45GIP1 | 7.29e-07 | 1024 | 46 | 10 | 24711643 |
| Pubmed | CARS1 DHX16 SART1 CIR1 EIF5B WDR3 UPF3B NOP56 AP3D1 KIF21A SURF6 | 7.47e-07 | 1297 | 46 | 11 | 33545068 | |
| Pubmed | Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation. | 9.51e-07 | 134 | 46 | 5 | 28695742 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 9.53e-07 | 807 | 46 | 9 | 22681889 | |
| Pubmed | 9.79e-07 | 251 | 46 | 6 | 28077445 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.17e-06 | 605 | 46 | 8 | 28977666 | |
| Pubmed | SMARCA2 NUSAP1 SART1 EIF5B KMT2A NCOR2 WBP11 UPF3B UBN2 ZNF292 | 1.43e-06 | 1103 | 46 | 10 | 34189442 | |
| Pubmed | 1.43e-06 | 268 | 46 | 6 | 33640491 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 1.50e-06 | 853 | 46 | 9 | 28718761 | |
| Pubmed | Cloning and characterization of two cytoplasmic dynein intermediate chain genes in mouse and human. | 1.71e-06 | 2 | 46 | 2 | 10049579 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 24695851 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 20657784 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.96e-06 | 283 | 46 | 6 | 30585729 | |
| Pubmed | 1.99e-06 | 650 | 46 | 8 | 38777146 | ||
| Pubmed | 2.83e-06 | 21 | 46 | 3 | 30110642 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 3.16e-06 | 934 | 46 | 9 | 33916271 | |
| Pubmed | 3.94e-06 | 713 | 46 | 8 | 29802200 | ||
| Pubmed | 4.33e-06 | 971 | 46 | 9 | 33306668 | ||
| Pubmed | 4.72e-06 | 731 | 46 | 8 | 29298432 | ||
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 4.76e-06 | 186 | 46 | 5 | 33637726 | |
| Pubmed | 4.91e-06 | 332 | 46 | 6 | 25693804 | ||
| Pubmed | Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l. | 5.13e-06 | 3 | 46 | 2 | 23361907 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 16239140 | ||
| Pubmed | 5.25e-06 | 86 | 46 | 4 | 37253089 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 6.75e-06 | 351 | 46 | 6 | 38297188 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 6.93e-06 | 1318 | 46 | 10 | 30463901 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 7.10e-06 | 202 | 46 | 5 | 33005030 | |
| Pubmed | 7.38e-06 | 777 | 46 | 8 | 35844135 | ||
| Pubmed | 1.16e-05 | 105 | 46 | 4 | 9628581 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 1.30e-05 | 394 | 46 | 6 | 27248496 | |
| Pubmed | 1.33e-05 | 601 | 46 | 7 | 33658012 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 1.37e-05 | 1425 | 46 | 10 | 30948266 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 1.50e-05 | 857 | 46 | 8 | 25609649 | |
| Pubmed | 1.54e-05 | 615 | 46 | 7 | 31048545 | ||
| Pubmed | 1.71e-05 | 5 | 46 | 2 | 25015291 | ||
| Pubmed | 1.71e-05 | 5 | 46 | 2 | 30250299 | ||
| Pubmed | 1.71e-05 | 5 | 46 | 2 | 16086288 | ||
| Pubmed | Nuclear localization of CBF1 is regulated by interactions with the SMRT corepressor complex. | 1.71e-05 | 5 | 46 | 2 | 11509665 | |
| Pubmed | 1.84e-05 | 419 | 46 | 6 | 15635413 | ||
| Pubmed | ANKRD11 EIF5B WDR3 KRI1 DNAJC21 WBP11 NOP56 AP3D1 SURF6 GKAP1 | 1.97e-05 | 1487 | 46 | 10 | 33957083 | |
| Pubmed | 2.03e-05 | 251 | 46 | 5 | 31076518 | ||
| Pubmed | 2.26e-05 | 653 | 46 | 7 | 33742100 | ||
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 9728334 | ||
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | 2.97e-05 | 272 | 46 | 5 | 25315684 | |
| Pubmed | 3.37e-05 | 47 | 46 | 3 | 32160526 | ||
| Pubmed | 3.45e-05 | 469 | 46 | 6 | 27634302 | ||
| Pubmed | 3.58e-05 | 7 | 46 | 2 | 12142566 | ||
| Pubmed | A role for SKIP in EBNA2 activation of CBF1-repressed promoters. | 3.58e-05 | 7 | 46 | 2 | 10644367 | |
| Pubmed | 3.58e-05 | 7 | 46 | 2 | 11751894 | ||
| Pubmed | A LIS1/NUDEL/cytoplasmic dynein heavy chain complex in the developing and adult nervous system. | 3.58e-05 | 7 | 46 | 2 | 11163259 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 4.21e-05 | 486 | 46 | 6 | 30940648 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 4.66e-05 | 495 | 46 | 6 | 27705803 | |
| Pubmed | 4.77e-05 | 8 | 46 | 2 | 25231297 | ||
| Pubmed | Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression. | 5.71e-05 | 56 | 46 | 3 | 26919559 | |
| Pubmed | Transport of the outer dynein arm complex to cilia requires a cytoplasmic protein Lrrc6. | 6.12e-05 | 9 | 46 | 2 | 27353389 | |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 6.51e-05 | 163 | 46 | 4 | 22113938 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 7.01e-05 | 533 | 46 | 6 | 30554943 | |
| Pubmed | 7.03e-05 | 60 | 46 | 3 | 20682791 | ||
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 7.43e-05 | 330 | 46 | 5 | 33301849 | |
| Pubmed | 7.75e-05 | 62 | 46 | 3 | 34516797 | ||
| Pubmed | 7.91e-05 | 1084 | 46 | 8 | 11544199 | ||
| Pubmed | 7.98e-05 | 335 | 46 | 5 | 15741177 | ||
| Pubmed | 8.25e-05 | 549 | 46 | 6 | 38280479 | ||
| Pubmed | 9.61e-05 | 1440 | 46 | 9 | 30833792 | ||
| Pubmed | Gene expression and cell identity controlled by anaphase-promoting complex. | 1.02e-04 | 68 | 46 | 3 | 32076268 | |
| Interaction | SMC5 interactions | ANKRD11 SART1 EIF5B WDR3 KRI1 KMT2A NCOR2 AFDN WBP11 LYAR NOP56 SMC5 UBN2 MGA ZC3H4 SURF6 | 2.92e-10 | 1000 | 46 | 16 | int:SMC5 |
| Interaction | POLR1G interactions | DHX16 ANKRD11 WDR3 KRI1 KMT2A WBP11 LYAR NOP56 UBN2 MGA SURF6 ZNF292 | 6.70e-10 | 489 | 46 | 12 | int:POLR1G |
| Interaction | NUP43 interactions | ANKRD11 WDR3 CD93 KRI1 KMT2A NCOR2 INO80 NOP56 UBN2 MGA SURF6 ZNF292 TTC14 | 8.62e-10 | 625 | 46 | 13 | int:NUP43 |
| Interaction | SNRNP40 interactions | DHX16 SART1 WDR3 KRI1 KMT2A NCOR2 WBP11 NOP56 UBN2 MGA ZC3H4 SURF6 TTC14 | 1.09e-09 | 637 | 46 | 13 | int:SNRNP40 |
| Interaction | NHLH1 interactions | 1.11e-09 | 88 | 46 | 7 | int:NHLH1 | |
| Interaction | MECP2 interactions | DHX16 SMARCA2 NUSAP1 SART1 FCF1 EIF5B WBP11 INO80 LYAR NOP56 PDCD7 SMC5 ZC3H6 ZC3H4 AP3D1 SURF6 ZNF292 | 1.31e-09 | 1287 | 46 | 17 | int:MECP2 |
| Interaction | MYCN interactions | SMARCA2 NUSAP1 SART1 FCF1 EIF5B WDR3 DNAJC21 KMT2A ANKRD17 WBP11 UPF3B LYAR NOP56 ZC3H4 MICAL2 GADD45GIP1 SURF6 | 3.50e-09 | 1373 | 46 | 17 | int:MYCN |
| Interaction | FBXO22 interactions | ANKRD11 SART1 DNAJC21 KMT2A NCOR2 NOP56 SMC5 ZC3H4 AP3D1 SURF6 ZNF292 | 2.64e-08 | 540 | 46 | 11 | int:FBXO22 |
| Interaction | ZNF330 interactions | DHX16 ANKRD11 NUSAP1 KRI1 KMT2A WBP11 LYAR NOP56 SURF6 ZNF292 | 5.09e-08 | 446 | 46 | 10 | int:ZNF330 |
| Interaction | POU5F1 interactions | SMARCA2 EIF5B ANKRD17 NCOR2 AFDN INO80 PDCD7 UBN2 MGA AP3D1 BRWD1 | 5.85e-08 | 584 | 46 | 11 | int:POU5F1 |
| Interaction | SIRT7 interactions | DHX16 SMARCA2 SART1 EIF5B WDR3 KRI1 KMT2A ANKRD17 AFDN LYAR NOP56 SURF6 | 7.20e-08 | 744 | 46 | 12 | int:SIRT7 |
| Interaction | BRD3 interactions | 1.32e-07 | 494 | 46 | 10 | int:BRD3 | |
| Interaction | CENPA interactions | 1.53e-07 | 377 | 46 | 9 | int:CENPA | |
| Interaction | HECTD1 interactions | ANKRD11 NUSAP1 SART1 WDR3 KRI1 DNAJC21 UPF3B LYAR NOP56 PDCD7 SMC5 AP3D1 SURF6 | 1.88e-07 | 984 | 46 | 13 | int:HECTD1 |
| Interaction | RPL31 interactions | DHX16 ANKRD11 FCF1 WDR3 KRI1 WBP11 UPF3B LYAR NOP56 GADD45GIP1 SURF6 | 2.71e-07 | 680 | 46 | 11 | int:RPL31 |
| Interaction | USP36 interactions | 7.75e-07 | 599 | 46 | 10 | int:USP36 | |
| Interaction | RPL4 interactions | ANKRD11 SART1 FCF1 WDR3 KRI1 DNAJC21 INO80 LYAR NOP56 CCDC140 SURF6 | 8.57e-07 | 764 | 46 | 11 | int:RPL4 |
| Interaction | POLR1E interactions | 1.12e-06 | 350 | 46 | 8 | int:POLR1E | |
| Interaction | DDX23 interactions | 1.15e-06 | 480 | 46 | 9 | int:DDX23 | |
| Interaction | PYHIN1 interactions | 1.33e-06 | 358 | 46 | 8 | int:PYHIN1 | |
| Interaction | DHX40 interactions | 1.43e-06 | 249 | 46 | 7 | int:DHX40 | |
| Interaction | FGFBP1 interactions | 1.77e-06 | 257 | 46 | 7 | int:FGFBP1 | |
| Interaction | MEN1 interactions | SART1 EIF5B WDR3 KRI1 KMT2A ANKRD17 AFDN INO80 LYAR ZC3H4 AP3D1 SURF6 | 2.28e-06 | 1029 | 46 | 12 | int:MEN1 |
| Interaction | GNL2 interactions | 2.33e-06 | 386 | 46 | 8 | int:GNL2 | |
| Interaction | EGR2 interactions | 2.42e-06 | 171 | 46 | 6 | int:EGR2 | |
| Interaction | EFTUD2 interactions | CARS1 SMARCA2 SART1 EIF5B KRI1 WBP11 UPF3B LYAR NOP56 SMC5 ZC3H4 AP3D1 DYNC1I2 KIF21A | 2.49e-06 | 1449 | 46 | 14 | int:EFTUD2 |
| Interaction | RPS24 interactions | 2.56e-06 | 529 | 46 | 9 | int:RPS24 | |
| Interaction | RNF113A interactions | SART1 CIR1 EIF5B ANKRD17 NCOR2 LYAR NOP56 ZC3H4 GADD45GIP1 SURF6 | 2.84e-06 | 692 | 46 | 10 | int:RNF113A |
| Interaction | APEX1 interactions | DHX16 ANKRD11 KRI1 KMT2A INO80 LYAR NOP56 SMC5 MGA DYNC1I2 SURF6 ZNF292 BRWD1 | 3.37e-06 | 1271 | 46 | 13 | int:APEX1 |
| Interaction | SUPT5H interactions | 3.51e-06 | 408 | 46 | 8 | int:SUPT5H | |
| Interaction | TERF2IP interactions | 3.63e-06 | 552 | 46 | 9 | int:TERF2IP | |
| Interaction | UTP23 interactions | 4.58e-06 | 191 | 46 | 6 | int:UTP23 | |
| Interaction | NOP56 interactions | 4.71e-06 | 570 | 46 | 9 | int:NOP56 | |
| Interaction | SURF6 interactions | 4.82e-06 | 426 | 46 | 8 | int:SURF6 | |
| Interaction | NIFK interactions | 5.25e-06 | 431 | 46 | 8 | int:NIFK | |
| Interaction | H3-3A interactions | 5.74e-06 | 749 | 46 | 10 | int:H3-3A | |
| Interaction | SRRM2 interactions | 8.72e-06 | 462 | 46 | 8 | int:SRRM2 | |
| Interaction | NAA40 interactions | DHX16 EIF5B KMT2A ANKRD17 CCDC43 UPF3B NOP56 SMC5 ZC3H4 AP3D1 SURF6 | 9.27e-06 | 978 | 46 | 11 | int:NAA40 |
| Interaction | NCL interactions | SART1 EIF5B KMT2A LYAR NOP56 SMC5 CCDC140 DYNC1I1 SURF6 BRWD1 | 1.00e-05 | 798 | 46 | 10 | int:NCL |
| Interaction | RBM19 interactions | 1.06e-05 | 221 | 46 | 6 | int:RBM19 | |
| Interaction | NUP50 interactions | 1.13e-05 | 341 | 46 | 7 | int:NUP50 | |
| Interaction | SOX2 interactions | SMARCA2 NUSAP1 EIF5B WDR3 KRI1 KMT2A ANKRD17 NCOR2 UPF3B LYAR NOP56 UBN2 ZNF292 | 1.15e-05 | 1422 | 46 | 13 | int:SOX2 |
| Interaction | RPL6 interactions | KRI1 DNAJC21 LYAR NOP56 CCDC140 GADD45GIP1 DYNC1I1 KIF21A SURF6 | 1.15e-05 | 637 | 46 | 9 | int:RPL6 |
| Interaction | KRI1 interactions | 1.17e-05 | 225 | 46 | 6 | int:KRI1 | |
| Interaction | CBX3 interactions | 1.29e-05 | 646 | 46 | 9 | int:CBX3 | |
| Interaction | RPLP0 interactions | 1.53e-05 | 660 | 46 | 9 | int:RPLP0 | |
| Interaction | DYNLT1 interactions | 1.72e-05 | 241 | 46 | 6 | int:DYNLT1 | |
| Interaction | RBM28 interactions | 1.85e-05 | 368 | 46 | 7 | int:RBM28 | |
| Interaction | RC3H1 interactions | 1.87e-05 | 677 | 46 | 9 | int:RC3H1 | |
| Interaction | RPL7A interactions | 1.91e-05 | 679 | 46 | 9 | int:RPL7A | |
| Interaction | MAFB interactions | 1.94e-05 | 246 | 46 | 6 | int:MAFB | |
| Interaction | SSRP1 interactions | 2.05e-05 | 685 | 46 | 9 | int:SSRP1 | |
| Interaction | PARN interactions | 2.15e-05 | 148 | 46 | 5 | int:PARN | |
| Interaction | TNIK interactions | 2.32e-05 | 381 | 46 | 7 | int:TNIK | |
| Interaction | RPL13 interactions | 2.43e-05 | 700 | 46 | 9 | int:RPL13 | |
| Interaction | RRP8 interactions | 2.59e-05 | 259 | 46 | 6 | int:RRP8 | |
| Interaction | REXO4 interactions | 2.70e-05 | 261 | 46 | 6 | int:REXO4 | |
| Interaction | IFI16 interactions | 2.84e-05 | 714 | 46 | 9 | int:IFI16 | |
| Interaction | H3C1 interactions | 2.85e-05 | 901 | 46 | 10 | int:H3C1 | |
| Interaction | COIL interactions | 3.14e-05 | 552 | 46 | 8 | int:COIL | |
| Interaction | RPS16 interactions | 3.17e-05 | 724 | 46 | 9 | int:RPS16 | |
| Interaction | SRSF1 interactions | 3.94e-05 | 570 | 46 | 8 | int:SRSF1 | |
| Interaction | CEBPZ interactions | 4.08e-05 | 281 | 46 | 6 | int:CEBPZ | |
| Interaction | DBN1 interactions | 4.12e-05 | 417 | 46 | 7 | int:DBN1 | |
| Interaction | FTSJ3 interactions | 4.44e-05 | 422 | 46 | 7 | int:FTSJ3 | |
| Interaction | NOP53 interactions | 4.68e-05 | 288 | 46 | 6 | int:NOP53 | |
| Interaction | RPL13A interactions | 5.09e-05 | 591 | 46 | 8 | int:RPL13A | |
| Interaction | NR2C2 interactions | DHX16 SMARCA2 FCF1 EIF5B WDR3 KRI1 KMT2A AFDN LYAR NOP56 SMC5 AP3D1 | 5.22e-05 | 1403 | 46 | 12 | int:NR2C2 |
| Interaction | EZH1 interactions | 5.73e-05 | 92 | 46 | 4 | int:EZH1 | |
| Interaction | LHX2 interactions | 5.92e-05 | 183 | 46 | 5 | int:LHX2 | |
| Interaction | KLF9 interactions | 5.98e-05 | 93 | 46 | 4 | int:KLF9 | |
| Interaction | SNRNP70 interactions | SART1 EIF5B KRI1 TRMT10A UPF3B LYAR NOP56 SMC5 ZC3H4 GADD45GIP1 | 6.02e-05 | 984 | 46 | 10 | int:SNRNP70 |
| Interaction | RPL23A interactions | 6.07e-05 | 606 | 46 | 8 | int:RPL23A | |
| Interaction | KLF6 interactions | 6.50e-05 | 95 | 46 | 4 | int:KLF6 | |
| Interaction | MLLT6 interactions | 6.50e-05 | 95 | 46 | 4 | int:MLLT6 | |
| Interaction | MNDA interactions | 6.73e-05 | 188 | 46 | 5 | int:MNDA | |
| Interaction | YY1 interactions | 7.04e-05 | 454 | 46 | 7 | int:YY1 | |
| Interaction | DOT1L interactions | 7.36e-05 | 807 | 46 | 9 | int:DOT1L | |
| Interaction | CEBPA interactions | SMARCA2 NUSAP1 SART1 EIF5B KMT2A NCOR2 WBP11 UPF3B NOP56 UBN2 ZNF292 | 8.59e-05 | 1245 | 46 | 11 | int:CEBPA |
| Interaction | BRD7 interactions | 8.61e-05 | 637 | 46 | 8 | int:BRD7 | |
| Interaction | H2BC12 interactions | 8.68e-05 | 322 | 46 | 6 | int:H2BC12 | |
| Interaction | FBL interactions | 8.79e-05 | 639 | 46 | 8 | int:FBL | |
| Interaction | ADNP interactions | 8.81e-05 | 199 | 46 | 5 | int:ADNP | |
| Interaction | DDRGK1 interactions | DHX16 NUSAP1 SART1 FCF1 EIF5B WDR3 KRI1 UPF3B LYAR NOP56 AP3D1 | 8.84e-05 | 1249 | 46 | 11 | int:DDRGK1 |
| Interaction | LHX1 interactions | 8.90e-05 | 103 | 46 | 4 | int:LHX1 | |
| Interaction | MKI67 interactions | 9.69e-05 | 648 | 46 | 8 | int:MKI67 | |
| Interaction | LRRC31 interactions | 1.01e-04 | 205 | 46 | 5 | int:LRRC31 | |
| Interaction | H1-4 interactions | 1.06e-04 | 656 | 46 | 8 | int:H1-4 | |
| Interaction | WDR36 interactions | 1.08e-04 | 208 | 46 | 5 | int:WDR36 | |
| Interaction | WBP4 interactions | 1.11e-04 | 109 | 46 | 4 | int:WBP4 | |
| Interaction | BUD13 interactions | 1.15e-04 | 110 | 46 | 4 | int:BUD13 | |
| Interaction | EN1 interactions | 1.15e-04 | 110 | 46 | 4 | int:EN1 | |
| Interaction | RC3H2 interactions | 1.18e-04 | 667 | 46 | 8 | int:RC3H2 | |
| Interaction | C7orf50 interactions | 1.35e-04 | 218 | 46 | 5 | int:C7orf50 | |
| Interaction | AFF4 interactions | 1.36e-04 | 115 | 46 | 4 | int:AFF4 | |
| Interaction | ZC3H18 interactions | 1.39e-04 | 877 | 46 | 9 | int:ZC3H18 | |
| Interaction | PARP1 interactions | DHX16 SMARCA2 SART1 WDR3 KRI1 LYAR NOP56 SMC5 MGA AP3D1 ZNF292 | 1.41e-04 | 1316 | 46 | 11 | int:PARP1 |
| Interaction | DBX2 interactions | 1.41e-04 | 8 | 46 | 2 | int:DBX2 | |
| Interaction | NIN interactions | 1.57e-04 | 359 | 46 | 6 | int:NIN | |
| Interaction | ETS1 interactions | 1.66e-04 | 121 | 46 | 4 | int:ETS1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 4.41e-04 | 147 | 46 | 3 | chr15q15 | |
| Cytoband | 15q15.1 | 1.03e-03 | 47 | 46 | 2 | 15q15.1 | |
| GeneFamily | WD repeat domain containing | 3.82e-05 | 262 | 27 | 5 | 362 | |
| GeneFamily | Dyneins, cytoplasmic | 1.66e-04 | 13 | 27 | 2 | 538 | |
| GeneFamily | Zinc fingers CCCH-type | 1.24e-03 | 35 | 27 | 2 | 73 | |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | 4.89e-06 | 389 | 46 | 7 | M39102 | |
| Coexpression | GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP | 1.62e-05 | 181 | 46 | 5 | M6849 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_DN | 2.32e-05 | 195 | 46 | 5 | M9808 | |
| Coexpression | GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_DN | 2.49e-05 | 198 | 46 | 5 | M8768 | |
| Coexpression | GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_DN | 2.62e-05 | 200 | 46 | 5 | M5806 | |
| Coexpression | GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP | 2.62e-05 | 200 | 46 | 5 | M8090 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | 3.26e-05 | 721 | 46 | 8 | M10237 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP | 4.89e-05 | 228 | 46 | 5 | M2151 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP | 7.19e-05 | 404 | 46 | 6 | M19488 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 8.55e-05 | 417 | 46 | 6 | M39224 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 1.09e-04 | 856 | 46 | 8 | M4500 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | 1.22e-04 | 644 | 46 | 7 | M10501 | |
| Coexpression | SHIRAISHI_PLZF_TARGETS_UP | 1.34e-04 | 10 | 46 | 2 | M1168 | |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP | 1.78e-04 | 477 | 46 | 6 | M40930 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 5.07e-07 | 469 | 45 | 9 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | NUSAP1 EIF5B DNAJC21 UPF3B LYAR NOP56 SMC5 UBN2 FEZ1 WASF1 KIF21A ZNF292 BRWD1 TTC14 | 1.08e-06 | 1459 | 45 | 14 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | NUSAP1 EIF5B DNAJC21 UPF3B LYAR NOP56 SMC5 UBN2 WASF1 KIF21A ZNF292 BRWD1 TTC14 | 1.27e-06 | 1257 | 45 | 13 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 2.33e-06 | 564 | 45 | 9 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 5.66e-06 | 629 | 45 | 9 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | NUSAP1 EIF5B DNAJC21 UPF3B LYAR NOP56 SMC5 FEZ1 DYNC1I2 KIF21A ZNF292 TTC14 | 7.83e-06 | 1252 | 45 | 12 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 9.10e-06 | 232 | 45 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 3.13e-05 | 595 | 45 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | 3.31e-05 | 989 | 45 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NUSAP1 DNAJC21 TRMT10A UPF3B LYAR SMC5 KIF21A ZNF292 BRWD1 GKAP1 | 3.31e-05 | 989 | 45 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | 4.22e-05 | 810 | 45 | 9 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.74e-05 | 311 | 45 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 5.14e-05 | 831 | 45 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 5.23e-05 | 192 | 45 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 6.11e-05 | 654 | 45 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 6.81e-05 | 203 | 45 | 5 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 7.37e-05 | 493 | 45 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | e9.5_NeuroEpith_OverFaceMesench_top-relative-expression-ranked_500 | 8.01e-05 | 342 | 45 | 6 | Facebase_ST1_e9.5_NeuroEpith_OverFaceMesench_500 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | NUSAP1 EIF5B DNAJC21 UPF3B LYAR NOP56 SMC5 MGA WASF1 KIF21A SURF6 | 1.03e-04 | 1371 | 45 | 11 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.18e-04 | 532 | 45 | 7 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | 1.85e-04 | 983 | 45 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000 | 1.85e-04 | 983 | 45 | 9 | Facebase_RNAseq_e9.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.85e-04 | 432 | 45 | 6 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | 2.90e-04 | 820 | 45 | 8 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | 3.24e-04 | 1060 | 45 | 9 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.06e-04 | 298 | 45 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | NUSAP1 EIF5B DNAJC21 LYAR NOP56 SMC5 FEZ1 WASF1 CCDC191 SURF6 | 4.22e-04 | 1347 | 45 | 10 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | NUSAP1 DNAJC21 UPF3B SMC5 FEZ1 CCDC191 DYNC1I2 KIF21A BRWD1 GKAP1 | 4.82e-04 | 1370 | 45 | 10 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 6.05e-04 | 498 | 45 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | NUSAP1 DNAJC21 UPF3B LYAR SMC5 FEZ1 WASF1 KIF21A ZNF292 BRWD1 | 6.19e-04 | 1414 | 45 | 10 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | 6.42e-04 | 1164 | 45 | 9 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 7.22e-04 | 192 | 45 | 4 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.78e-04 | 85 | 45 | 3 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k1_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.66e-04 | 361 | 45 | 5 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | 1.01e-03 | 1241 | 45 | 9 | facebase_RNAseq_e10.5_MandArch_2500_K1 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.28e-09 | 197 | 46 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 4.54e-08 | 192 | 46 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 5.13e-08 | 196 | 46 | 6 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 5.61e-08 | 199 | 46 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.81e-06 | 197 | 46 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.90e-06 | 199 | 46 | 5 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.90e-06 | 199 | 46 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.88e-05 | 153 | 46 | 4 | 88ca2d2c2ab19fbee13e18951b993ee05dd30f67 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.88e-05 | 153 | 46 | 4 | 553dff9688a1996d8f4ba16e60c683593d781389 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 3.95e-05 | 185 | 46 | 4 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.20e-05 | 188 | 46 | 4 | 0476d7ee3e0ce78c3c5b111e9ade01098f9ea7ec | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-05 | 195 | 46 | 4 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-05 | 195 | 46 | 4 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.94e-05 | 196 | 46 | 4 | a7291291931f9e5abd6a54349bc920a0ab68a4cb | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 5.24e-05 | 199 | 46 | 4 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 5.24e-05 | 199 | 46 | 4 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 46 | 4 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.31e-04 | 49 | 30 | 3 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.52e-04 | 50 | 30 | 3 | GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1 | |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA | 2.42e-06 | 193 | 46 | 6 | 1081_DN | |
| Disease | Neurodevelopmental Disorders | 9.44e-06 | 93 | 42 | 4 | C1535926 | |
| Disease | Abnormality of nervous system morphology | 8.84e-05 | 10 | 42 | 2 | C4022810 | |
| Disease | Microcephaly | 1.21e-04 | 67 | 42 | 3 | C0025958 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 4.06e-04 | 101 | 42 | 3 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 4.08e-04 | 21 | 42 | 2 | EFO_0004616, EFO_0010726, EFO_1000786 | |
| Disease | age at menarche | 1.49e-03 | 594 | 42 | 5 | EFO_0004703 | |
| Disease | Small cell carcinoma of lung | 2.70e-03 | 54 | 42 | 2 | C0149925 | |
| Disease | sexual dimorphism measurement | 4.53e-03 | 1106 | 42 | 6 | EFO_0021796 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KKEKKKREKEALRQA | 166 | P55196 | |
| LKEKKKREKHREKWR | 1456 | Q6UB99 | |
| YRKRRAKREEKKEKK | 606 | Q9NPY3 | |
| TNEKKREKRRKKKEQ | 51 | Q5VSY0 | |
| REKRKEKRRKKKEEQ | 1481 | O75179 | |
| EKRRKKKEEQRRKLE | 1486 | O75179 | |
| KRKKRKHLRKKREEE | 121 | O60231 | |
| EEMKKKKERKRRKER | 141 | Q96MF4 | |
| KKERKRRKERKKERN | 146 | Q96MF4 | |
| KLEKDKRRKKRKEKE | 736 | O14617 | |
| KLKKVKKKRRRDEEL | 221 | Q9ULG1 | |
| RDKLAKQERKEKEKK | 201 | Q96MW1 | |
| LKMEKERNARRKKKK | 671 | Q9Y618 | |
| TRKLEKQEKKRLKKE | 436 | O00567 | |
| REEEEQLKEKKKRKK | 1126 | Q8IWI9 | |
| IREEKKRKEEERKKK | 21 | O14576 | |
| IREEKKRKEEERKKK | 21 | Q13409 | |
| KRELEKKQRKEKEKI | 386 | Q8N8D1 | |
| KREETRERKKREKAK | 331 | Q8N9T8 | |
| QKEQRELMKKRRKEK | 281 | Q99689 | |
| KKREQERKEKKAKVL | 416 | Q9BXS6 | |
| KENKKIRDKARKEKN | 186 | Q5F1R6 | |
| KRKRKDIEKLKKIDR | 241 | Q9BZI7 | |
| DQRLKEKDRLKPKKK | 21 | Q9Y324 | |
| RKREEKRLKKMKELE | 711 | Q8NCU4 | |
| KRERKDKVSKETKKR | 226 | Q8WUF8 | |
| RKRKKENKPKKENLR | 911 | Q9NSI6 | |
| KNKRERKEERQKKRK | 186 | Q9NX58 | |
| RKEERQKKRKREKKE | 191 | Q9NX58 | |
| QKKRKREKKELKLEN | 196 | Q9NX58 | |
| ERKRLKEEKQKRKKE | 186 | Q8TAE8 | |
| EKENKRESRKEKRKK | 881 | Q03164 | |
| LERKLKKERKKEERQ | 66 | Q9BRJ6 | |
| KEKKTLRRRKKLEKA | 1776 | O94851 | |
| REEKRRVEEEKRKKK | 651 | P49589 | |
| KKKRRRRKKKAEENA | 556 | P51531 | |
| KRERKKQKEKERKER | 386 | O60841 | |
| KQKEKERKERLKKEG | 391 | O60841 | |
| KRKRKELRAKEKARK | 156 | O75683 | |
| RKLDRLEKKKKKKDR | 226 | Q86X95 | |
| RKRKEEGEKEKKPRK | 281 | Q6ZU65 | |
| EREKKKSKRRKREKH | 56 | P61129 | |
| KREAAKKKQERKKRA | 131 | Q9H3J6 | |
| KKKQERKKRAKETLE | 136 | Q9H3J6 | |
| EKLKRKEKRKKKRLQ | 546 | Q7Z4S6 | |
| KEKRKKKRLQKLEES | 551 | Q7Z4S6 | |
| KIRRHKKEKEEKKRK | 2081 | O60281 | |
| LLKEEKRLKKKRRKS | 461 | Q96N46 | |
| KTKRRVKKIRKKEKE | 401 | O43290 | |
| RRLKRKRKKEREKEK | 101 | Q9UPT8 | |
| KRKKEREKEKRRSKK | 106 | Q9UPT8 | |
| EQRELRKQKRKEKRK | 56 | Q8TBZ6 | |
| DKRKEKRKQKQKNLD | 171 | Q92558 | |
| EEKKRKRKKREKLIL | 926 | Q9UNX4 | |
| ARKEARKRELKKNKK | 21 | Q9Y2W2 | |
| RQKKKELLERKTKKR | 691 | Q8IY18 |